Why the study?
Does clopidogrel therapy increase surgical delay and mortality in elderly patients with hip fractures compared to aspirin or no antiplatelet therapy?
Population
180 patients aged over 65 years with either an intertrochanteric or femoral neck fracture
Comparison
Clopidogrel therapy vs Control group
Design
Cohort
Follow-up
30-day
Authors
Loading...
May warrant individualized perioperative strategies in clopidogrel-treated hip fracture patients; leaves open causality and optimal timing in prospective trials.
Does clopidogrel therapy increase surgical delay and mortality in elderly patients with hip fractures compared to aspirin or no antiplatelet therapy?
In elderly patients with hip fractures, clopidogrel use is associated with significant surgical delay, which correlates with increased 30-day mortality.
Harty et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: